Molecular Enzymology and Drug Targets

  • Journal h-index: 5
  • Journal CiteScore: 0.46
  • Journal Impact Factor: 0.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • Publons
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Articles published in Molecular Enzymology and Drug Targets have been cited by esteemed scholars and scientists all around the world. Molecular Enzymology and Drug Targets has got h-index 5, which means every article in Molecular Enzymology and Drug Targets has got 5 average citations.

Following are the list of articles that have cited the articles published in Molecular Enzymology and Drug Targets.

  2022 2021 2020 2019 2018

Year wise published articles

20 11 16 20 4

Year wise citations received

6 8 12 5 8
Journal total citations count 54
Journal Impact Factor 0.45
Journal 5 years impact factor 0.55
Journal CiteScore 0.46
Journal h-index 5
Journal Impact Factor 2020 formula
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year
Journal 5-year Impact Factor 2020 formula
Citations(2016 + 2017 + 2018 + 2019 + 2020)/
{Published articles(2016 + 2017 + 2018 + 2019 + 2020)}
Journal CiteScore
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3
Important citations
Time-dependent inhibition of PHD2.
Production and evaluation of a 67 Ga-labeled anti-Ror1 monoclonal antibody in a mouse model of breast cancer
In-Silico Drug discovery approach targeting receptor tyrosine kinase-like orphan receptor 1 for cancer treatment.
Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
A Current Review on the Pathogenesis and Treatments of Vitiligo
Association of human leukocyte antigen-DRB1 with the response in patients with vitiligo
Novel immunological and genetic factors associated with vitiligo: A review
Acute Pancreatitis: An Extremely Rare Complication of Etoricoxib
Investigation of histological effects of 5-(4-methyltiobenzylidene) thiazolotriazol on liver enzyme changes & extracellular structures of Trichogaster trichopteru’s liver
Assessment of the safety, tolerability and effectiveness of first Russian generic aceclofenac in patients with undifferentiated peripheral inflammatory arthritis
A comparative study of the hepatotrophic properties of non-steroidal anti-inflammatory drugs
Inflammatory and oxidative stress parameters as potential early biomarkers for silicosis.
The Role of Apoptosis as a Double-Edge Sword in Cancer
A World of Wonders: Interleukin-1 (IL-1) and IL-2 Families
Modeling of apoptosis through gene interaction network and analysis of gene expression pattern
Proapoptotic Index Evaluation of Two Synthetic Peptides Derived from the Coneshell Californiconus californicus in Lung Cancer Cell Line H1299.
‘Polymorphism-aided’ Selective Targeting and Inhibition of Caspase-6 by a Novel Allosteric Inhibitor Towards Efficient Alzheimer’s Disease Treatment
Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy.
Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review
SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development.